Skip navigation
  • Home
  • Browse
    • Communities
      & Collections
    • Browse Items by:
    • Publication Date
    • Author
    • Title
    • Subject
    • Department
  • Sign on to:
    • My MacSphere
    • Receive email
      updates
    • Edit Profile


McMaster University Home Page
  1. MacSphere
  2. Open Access Dissertations and Theses Community
  3. Open Access Dissertations and Theses
Please use this identifier to cite or link to this item: http://hdl.handle.net/11375/7067
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorWright, Gerard D.en_US
dc.contributor.authorThompson, Paul R.en_US
dc.date.accessioned2014-06-18T16:37:57Z-
dc.date.available2014-06-18T16:37:57Z-
dc.date.created2010-06-30en_US
dc.date.issued1999-08en_US
dc.identifier.otheropendissertations/2363en_US
dc.identifier.other3367en_US
dc.identifier.other1376617en_US
dc.identifier.urihttp://hdl.handle.net/11375/7067-
dc.description.abstract<p>While the aminoglycoside antibiotics continue to be useful chemotherapeutic agents, the appearance and dissemination of high level aminoglycoside resistant strains is a threat to the future clinical relevance of these antibiotics. Since there are only a limited number of alternative antibiotics, and resistance to all of these therapies has been observed, there is an urgent need to either introduce new classes of antibiotics or to 'rehabilitate' the ones currently employed. The development of drugs that inhibit the resistance mechanism is one method to 'rehabilitate' the usefulness of these antibiotics. As such, we are employing structure based drug design techniques for the development of inhibitors to several enzymatic aminoglycoside resistance mechanisms. A prerequisite for this method of drug design is a thorough knowledge of the catalytic mechanism of the enzyme, and as such I have characterized the regiospecificity and phosphoryl transfer mechanism of two aminoglycoside phosphotransferases: APH(3' )-IIIa and APH(9)-1a. From these studies, described herein, it is now known that the APH(3' )-IIIa enzyme catalyzes the direct transfer of the γ-phosphate of ATP to either the 3' -hydroxyl of 4,6-disubstituted aminoglycosides, or the 3' - and 5'' -hydroxyl of 4,5-disubstituted aminoglycosides, providing that both hydroxyl groups are present. It is also now known that APH(9)-la catalyzes the transfer of the γ-phosphate of ATP to the 9-hydroxyl of spectinomycin. Site directed mutagenesis, kinetic, metal, solvent isotope, and solvent viscosity studies of these two enzymes indicate that a dissociative-like transition state is employed, and that phosphate transfer occurs through a biomechanical process.</p>en_US
dc.subjectBiochemistryen_US
dc.subjectBiochemistryen_US
dc.titleCharacterization of the catalytic mechanisms of two aminoglycoside phosphotransferases: APH(3')-IIIa from Enterococcus faecalis and APH(9)-Ia from Legionella pneumophilaen_US
dc.typethesisen_US
dc.contributor.departmentBiochemistryen_US
dc.description.degreeDoctor of Philosophy (PhD)en_US
Appears in Collections:Open Access Dissertations and Theses

Files in This Item:
File SizeFormat 
fulltext.pdf
Open Access
12.2 MBAdobe PDFView/Open
Show simple item record Statistics


Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.

Sherman Centre for Digital Scholarship     McMaster University Libraries
©2022 McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L8 | 905-525-9140 | Contact Us | Terms of Use & Privacy Policy | Feedback

Report Accessibility Issue